AstraZeneca India (AZIPL), the Global Capability Centre (GCC) of AstraZeneca, announced an investment of 250 crore rupees ($30 million) to expand its Global Innovation and Technology Centre (GITC) in Chennai, Tamil Nadu, which includes close to 1,300 roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally.
The expanded facility was inaugurated today in a ceremony officiated by the Honourable Minister of Industries Tamil Nadu, Dr T.R.B. Rajaa, British Deputy High Commissioner to India, Christina Scott CMG, AstraZeneca Vice President for Asia Area Sylvia Varela, as well as AstraZeneca’s leadership team in the country.
The investment marks a significant milestone in AstraZeneca’s growth story in India as it celebrates its 45 year in the country this month.
Dr Sanjeev Panchal, Managing Director & Country President AstraZeneca Pharma India (AZPIL), said, “India’s rich talent pool and dynamic ecosystem for digital advancements make it a pivotal hub for our global operations. This strategic investment underscores our dedication to improving patient outcomes through cutting-edge technology and reinforces our aspiration to transform the future of the healthcare industry.”
Thiru. MK Stalin, Chief Minister of Tamil Nadu said, “Technology is the driving force behind innovation and we are committed to make Tamil Nadu an epicentre of technology and research. This collaboration with AstraZeneca aligns perfectly with our vision to foster innovation and create high-value opportunities for the people of Tamil Nadu. We are committed to ensure Tamil Nadu’s position as a premier investment destination for companies around the world.”
Dr T.R.B. Rajaa, Industries Minister, Tamil Nadu said, “ This investment will not only enhance our state’s capabilities in the pharmaceutical and healthcare sectors but also spur technological advancements and economic development. With this expansion and talent exposure, AstraZeneca is contributing to our vision of making Tamil Nadu a global hub for innovation-driven industries.”
The facility currently occupies 334,000 square feet of office space at Ramanujan IT City, with plans to add approximately 180,000 square feet over the next six months to accommodate this expansion, creating AstraZeneca’s biggest global capability centre.